Patterns of disease relapse and posttreatment follow-up of patients with resected pancreatic adenocarcinoma: A single-center analysis.
Beatriz A GonzalesAlessandro L DinizSilvio Melo TorresHéber Salvador de Castro RibeiroIgor Correia de FariasAndré Luís de GodoyFelipe J F CoimbraVictor Hugo Fonseca de JesusPublished in: Journal of surgical oncology (2022)
A follow-up protocol that included imaging studies every 3 months in the first 2 years and every 6 months thereafter is able to diagnose disease relapse when patients have adequate performance status and are still able to undergo additional anticancer treatment.